Skip to main content Skip to main navigation menu Skip to site footer
Reumatismo - The Italian Journal of Rheumatology

eISSN 2240-2683

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: M.A. Cimmino, Genova, Italy

1.0
Impact Factor 2024
1.7
CiteScore 2024
1.0
Impact Factor 2024
1.7
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

    Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker
    85-91
    06-07-2018
    https://doi.org/10.4081/reumatismo.2018.1027
    2743
    PDF: 1540
  • Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio

    E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti
    62-67
    16-09-2015
    https://doi.org/10.4081/reumatismo.2015.828
    2706
    PDF: 1199
  • Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

    L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria
    314-320
    11-12-2012
    https://doi.org/10.4081/reumatismo.2012.314
    2565
    PDF: 1302
  • Typing TREX1 gene in patients with systemic lupus erythematosus

    M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani
    1-7
    30-06-2015
    https://doi.org/10.4081/reumatismo.2015.782
    3315
    PDF: 1805
  • Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case

    D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav
    302-306
    17-03-2014
    https://doi.org/10.4081/reumatismo.2013.706
    4942
    PDF: 1357
  • Urinary CXCL10: a marker of nephritis in lupus patients

    M. A. Marie, R. E. Abu Khalil, H. M. Habib
    292-297
    17-03-2014
    https://doi.org/10.4081/reumatismo.2013.719
    3069
    PDF: 1731
  • Short story of antirheumatic therapy.VIII. The immunodepressants

    G. Pasero, P. Marson
    44-54
    19-03-2012
    https://doi.org/10.4081/reumatismo.2012.44
    1645
    PDF: 1507
  • Systemic lupus erythematosus presenting as fulminant lupus pneumonitis: a rare case report

    H.K. Aggarwal, D. Jain, A. Mittal, A. Rao, R.K. Yadav, P. Jain
    48-52
    23-06-2016
    https://doi.org/10.4081/reumatismo.2016.846
    3018
    PDF: 1772
  • Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

    M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini
    321-325
    11-12-2012
    https://doi.org/10.4081/reumatismo.2012.321
    1925
    PDF: 1285
  • Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

    A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni
    350-359
    20-12-2012
    https://doi.org/10.4081/reumatismo.2012.350
    3212
    PDF: 2701
  • The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

    M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani
    137-143
    16-12-2016
    https://doi.org/10.4081/reumatismo.2016.891
    2296
    PDF: 1376
  • Pain and systemic lupus erythematosus

    M. Di Franco, M.P. Guzzo, F.R. Spinelli, F. Atzeni, P. Sarzi-Puttini, F. Conti, C. Iannuccelli
    33-38
    06-06-2014
    https://doi.org/10.4081/reumatismo.2014.762
    5392
    PDF: 2894
  • Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

    F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò
    100-105
    06-07-2018
    https://doi.org/10.4081/reumatismo.2018.1023
    2549
    PDF: 1482
  • Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

    E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli
    175-183
    21-12-2017
    https://doi.org/10.4081/reumatismo.2017.1007
    3540
    PDF: 1834
  • Systemic vasculitis in a patient with rhupus syndrome

    O. Zengin, M. E. Onder, M. A. Sarica, I. H. Turkbeyler, G. Kimyon, Z. H. Demir, H. Yildiz, B. Kisacik, A. M. Onat
    161-164
    23-05-2016
    https://doi.org/10.4081/reumatismo.2015.858
    2004
    PDF: 1091
  • Spontaneous soft tissue haemorrhage in systemic lupus erythematosus

    M.C. Abdulla
    199-202
    31-12-2016
    https://doi.org/10.4081/reumatismo.2016.952
    1945
    PDF: 914
  • Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study

    A.B. Rasheed, M.S. Daoud, F.I. Gorial
    170-174
    21-12-2017
    https://doi.org/10.4081/reumatismo.2017.998
    1885
    PDF: 825
  • Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

    N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria
    380-387
    20-12-2012
    https://doi.org/10.4081/reumatismo.2012.380
    2441
    PDF: 1005
  • Osteoporosis and rheumatic diseases

    N. Maruotti, A. Corrado, F.P. Cantatore
    125-135
    28-06-2014
    https://doi.org/10.4081/reumatismo.2014.785
    8383
    PDF: 3550
  • PO:16:238 | Cardiovascular risk in systemic lupus erythematosus patients: comparison among Framingham Score, QRISK3, and SLECRE Francesca Vignoni1|2, Serena Iodice2, Cesare Tomasi2, Chiara Orlandi1|2, Eleonora Pedretti1, Micaela Fredi2, Franco Franceschini1|2, Ilaria Cavazzana1|2. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2045
    19
  • Temporomandibular joint dysfunction in various rheumatic diseases

    F.J. Aceves-Avila, M. Chávez-López, J.R. Chavira-González, C. Ramos-Remus
    126-130
    24-07-2013
    https://doi.org/10.4081/reumatismo.2013.126
    4213
    PDF: 1519
  • The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

    W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi
    241-250
    20-12-2018
    https://doi.org/10.4081/reumatismo.2018.1075
    1716
    PDF: 1099
  • PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino1, Giulia Pazzola1, Luca Ronzoni3, Andreina Teresa Manfredi1|2, Carlo Salvarani1|2 | 1SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; 2Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; 3SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2146
    18
  • A rare form of anemia in systemic lupus erythematosus

    C.A. Mansoor, R. Narayan
    119-121
    21-09-2017
    https://doi.org/10.4081/reumatismo.2017.982
    3159
    PDF: 1088
  • PO:16:232 | Belimumab step-down dose spacing in patients with systemic lupus erythematosus in persistent clinical remission: experience from a multicentric cohort Alice Bartoletti1, Laura Giudice1, Lorenza Maria Argolini1|2, Giuseppe Alvise Ramirez3, Luca Moroni3, Tommaso Schioppo4, Chiara Bellocchi5|6, Annalaura Fasiello6, Lorenzo Beretta6, Lorenzo Dagna3, Roberto Caporali1, Maria Gerosa1. | 1UO Clinica Reumatologica, ASST Gaetano Pini CTO, Milano, Italy; 2UOC Medicina fisica e riabilitazione specialistica, ASST Gaetano Pini CTO, Milano, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffa Milano Italy; 4Medicina Generale II, Servizio di Reumatologia, Ospedale San Paolo, ASST Santi Paolo Carlo, Milano, Italy; 5Department of Clinical Sciences and Community Health, University of Milan, Dipartimeto di Eccellenza 2023-2027, Milano, Italy; 6Referral Centre for Systemic Autoimmune DIseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2044
    18
  • Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

    C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani
    91-96
    https://doi.org/10.4081/reumatismo.2011.91
    1328
    PDF: 776
  • PO:15:208 | Impact of disease control on organ damage accrual in patients with systemic lupus erythematosus with and extra-renal flares: a 12-month single-center longitudinal study Giorgia Capozzo1, Marco Oliva1, Giancarlo Cascarano1, Chiara Cardelli1, Dina Zucchi1, Chiara Stagnaro2, Viola Signorini2, Elena Elefante2, Chiara Tani1, Marta Mosca1. | 1Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale, Pisa, Italy; 2Azienda Ospedaliero Universitaria Pisana, U.O. Reumatologia, Pisa, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2037
    19
  • PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli1|2, Chiara Tani1, Luca Moroni3, Filippo Vesentini4, Francesca Bottazzi5, Micaela Fredi6, Ettore Silvagni7, Matteo Piga8, Flavia Riccio9, Fulvia Ceccarelli10, Ginevra De Marchi11, Edoardo Biancalana12, Gianluca Moroncini13, Rita Mulè14, Mariele Gatto15, Laura Coladonato16, Paola Conigliaro17, Maria Gerosa18, Andrea Picchianti Diamanti19, Benedetta Bianchi20, Federica Maiolini20, Michela Gasparotto20, Serena Guiducci20, Maria Ilenia De Andres20, Alberto Lo Gullo20, Silvia Noviello20, On Behalf Of The Reveal Investigators20, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; 2Department of Medical Biotechnologies, University of Siena, Siena; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; 4Rheumatology Unit, Department of Medicine, University of Padua, Padova; 5Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 6Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; 8Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari;  9Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; 10Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; 11Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; 12Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; 13Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 14Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; 15Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; 16Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; 17Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; 18Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; 19Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; 20Italian REVEAL Study Group Italy, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2031
    23
  • The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

    P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo
    109-113
    https://doi.org/10.4081/reumatismo.2005.109
    1055
    PDF: 3828
  • Clinical profile of patients with lupus psychosis in a Colombian cohort

    M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García
    13-09-2022
    https://doi.org/10.4081/reumatismo.2022.1483
    1468
    PDF: 760
  • Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019

    D.G. Fernández Ávila, M. Rivera Maldonado, L.P. Charry Anzola
    08-05-2023
    https://doi.org/10.4081/reumatismo.2023.1568
    1597
    PDF: 1207
  • PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato1, Laura Coladonato1, Marco Fornaro1, Marlea Lavista1, Daniele Sabella1, Marco Capodiferro1, Maria Morrone1, Crescenzio Scioscia1, Giuseppe Lopalco1, Florenzo Iannone1 | 1Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area JonicaJ, University of Bari, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2161
    26
  • PO:17:253 | Unveiling the gap: a multicenter study on factors driving patient-physician discrepancies in assessing disease activity in systemic lupus erythematosus Giorgia Ingrid Gozzoli1, Micaela Fredi1, Federica Bonaso1, Silvia Ebe Lucia Della Pina1, Claudia Barison1, Irene Lorenzini4, Raffaele Pericotti4, Anna Mattiuzzo4, Marcelo Neto2, Sofia Azevedo3, Cláudia Oliveira3, Cesare Tomasi4, Luís Sousa Inês2, Franco Franceschini1. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 2Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; 3Rheumatology  Department, ULS Aveiro, Aveiro, Portugal; 4Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2046
    18
  • Quality of life measures in systemic lupus erythematosus: a systematic review

    M. Radin, G. El Hasbani, A. Barinotti, D. Roccatello, I. Uthman, A. Taher, S. Sciascia
    07-02-2022
    https://doi.org/10.4081/reumatismo.2021.1447
    7961
    PDF: 2238
  • PO:14:207 | Nailfold capillaroscopy in systemic lupus erythematosus: microvascular alterations and their clinical relevance Giulia Cassone1, Filippo Santoro2, Maria Grazia Malandra2, Bruno Biasi2, Elena Vanni2, Caterina Vacchi1, Alesandra Carobbio3, Dilia Giuggioli1|2. | 1Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 2Università di Modena e Reggio Emilia, Modena, Italy; 3Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Univeristà di Modena e Reggio Emilia, Modena, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2036
    18
  • Drug-induced lupus erythematosus

    F. Atzeni, M.G. Marrazza, P. Sarzi-Puttini, M. Carrabba
    147-154
    https://doi.org/10.4081/reumatismo.2003.147
    7386
    PDF: 18488
  • PO:14:206 | Factors impacting subjective cognitive impairment in systemic lupus erythematosus patients: clearing away the lupus brain fog Elisabetta Chessa1, Marta Paola Pireddu2, Fabio Congiu2, Giulia Rizzo2, Cristina Serafini3, Elena Ragusa2, Alberto Cauli1|2, Matteo Piga1|2. | 1SC Reumatologia- AOU Cagliari, Cagliari, Italy; 2Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy; 3PO Sirai - Unità di Nefrologia e Dialisi, Carbonia (CA), Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2035
    21
  • PO:14:203 | Impact of anifrolumab on depressive symptoms in systemic lupus erythematosus: results from a single-centre prospective observational study Luca Moroni1, Biancamaria Venerandi1, Maria Cilona1, Anna Vivona1, Gabriele Gallina1, Giovanni Benanti1, Enrica Bozzolo1, Giuseppe Ramirez1, Marco Matucci-Cerinic1, Lorenzo Dagna1. | 1U.O. di Immunologia, Reumatologia, Allergologia e Malattie Rare - IRCCS Ospedale San Raffaele, Milano, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2032
    18
  • Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review

    S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano
    24-09-2024
    https://doi.org/10.4081/reumatismo.2024.1647
    915
    PDF: 298
  • The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

    Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino
    23-07-2025
    https://doi.org/10.4081/reumatismo.2025.1830
    1076
    PDF: 12
  • PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus Antonella Grimaldi1, Giuseppe Alessandrini2, Laura Quarta1, Maria Rita Ricciardi1, Daniela Costanza1, Clara Minerba1, Eugenio Quarta1 | 1UOC Reumatologia Verona; 2Specialista Dermatologo in Libera Professione, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2170
    27
  • PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case Angela Carenza1, Liliana Dinoia2, Sergio De Gioia2, Federica Gatti1, Teresa Caferri1, Lucia Cristiana Colaprico1, Angelica Napoletano1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit, University of Bari, Department of Precision and Regenerative Medicine, Jonian area DiMePRe-J, Bari, Italy; 2Azienda Sanitaria Locale di Taranto, presidio ospedaliero SS. Annunziata, Unità Operativa di Reumatologia, Taranto, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2047
    20
  • Clinical profile of patients with lupus nephritis

    T.L. Skare, A.C. Schönrock
    316-317
    https://doi.org/10.4081/reumatismo.2009.316
    1021
    PDF: 700
  • Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

    A.A. Akpabio, B.I. Otike-Odibi
    115-119
    23-07-2020
    https://doi.org/10.4081/reumatismo.2020.1274
    1198
    PDF: 701
  • PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology Davide Rozza1, Carlo Alberto Scirè1|2, Paola Conigliaro3, Giacomo Emmi4, Laura Coladonato6, Salvatore Scarpato7, Luca Iaccarino8, Serena Guiducci9, Giulia Pazzola10, Francesca Romana Spinelli11, Micol Frassi12, Ilaria Cavazzana12, Chiara Scirocco13, Valeria Orefice13, Immacolata Prevete13, Alessandra Bortoluzzi14, Marcello Govoni14, Elena Bartoloni15, Luca Moroni16, Giuseppe Alvise Ramirez16, Valentina Canti16, Giorgio Pettiti17, Maria Chiara Ditto18, Enrico Fusaro18, Marta Mosca19, Lorenzo Cavagna20, Fabrizio Conti11, Andrea Doria8, Gian Domenico Sebastiani13, Sperimentatori Gruppo Lire5 | 1Centro Studi della Società Italiana di Reumatologia, Milano; 2Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; 3Università di Roma Tor Vergata; 4Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; 5https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; 6Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; 7Azienda Sanitaria Locale ASL Salerno; 8Università degli Studi di Padova; 9SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 10Arcispedale Santa Maria Nuova Reggio Emilia; 11Università degli Studi di Roma La Sapienza; 12Spedali Civili di Brescia; 13Azienda Ospedaliera San Camillo Forlanini, Roma; 14Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; 15SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; 16IRCCS Ospedale San Raffaele, Milano; 17Azienda Ospedaliera S. Croce e Carle, Cuneo; 18AOU Citta' della Salute e della Scienza di Torino; 19AOU Santa Chiara, Pisa; 20Università di Pavia, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2158
    28
  • PO:11:167 | Subtle symptoms masking a challenging diagnosis: a clinical case of intestinal vasculitis in systemic lupus erythematosus Ilaria Pace1, Giulia Rizzo1, Elisabetta Chessa2, Davide Corradini1, Roberta Origa1, Valentina Ibba2, Alberto Floris1|2, Alberto Cauli1|2, Matteo Piga1|2 | 1Sapienza Università di Roma; 2SC Reumatologia, AOU Cagliari, Cagliari, Italy 

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2153
    22
  • Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients

    I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta
    17-07-2023
    https://doi.org/10.4081/reumatismo.2023.1541
    1199
    PDF: 656
  • Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis

    L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca
    203-204
    31-10-2013
    https://doi.org/10.4081/reumatismo.2013.203
    2649
    PDF: 721
    Appendix: 342
  • Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

    D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes
    24-09-2024
    https://doi.org/10.4081/reumatismo.2024.1658
    1001
    PDF: 329
  • Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report

    L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello
    17-07-2023
    https://doi.org/10.4081/reumatismo.2023.1597
    1242
    PDF: 787
1 - 50 of 125 items 1 2 3 > >> 
Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Analytics
  • Società Italiana di Reumatologia
Vol. 77 No. 4 (2025)
Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience
Carmela Coccia et al.
4 August 2025
Vol. 77 No. 4 (2025)
Paratenon effusion of the Achilles tendon: a rare finding
Raphael Micheroli et al.
1 September 2025
Vol. 77 No. 4 (2025)
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
Fulvia Ceccarelli et al.
23 July 2025
Vol. 77 No. 4 (2025)
The diagnostic utility of miRNA21 in systemic sclerosis
Gehad Gamal Maghraby et al.
25 September 2025

Keywords

Reumatismo - The Italian Journal of Rheumatology

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 0048-7449
eISSN: 2240-2683

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy